Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma

NCT01375972 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Biliary Cancer

Interventions

DRUG: S-1 plus cisplatin
DRUG: Gemcitabine plus Cisplatin

Sponsor

Asan Medical Center